Business Description
BG Medicine Inc
NAICS : 621511
SIC : 2835
ISIN : US08861T2069
Compare
Compare
Traded in other countries / regions
BGMD.USARBM1.Germany Description
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.93 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -115.85 | |||||
| Beneish M-Score | -4.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -33.6 | |||||
| 3-Year EBITDA Growth Rate | -50.9 | |||||
| 3-Year EPS without NRI Growth Rate | -46.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.65 | |||||
| Quick Ratio | 1.53 | |||||
| Days Inventory | 194.47 | |||||
| Days Sales Outstanding | 42.19 | |||||
| Days Payable | 402.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.69 | |||||
| Operating Margin % | -295.59 | |||||
| Net Margin % | -338.57 | |||||
| FCF Margin % | -235.75 | |||||
| ROA % | -180.66 | |||||
| ROC (Joel Greenblatt) % | -9777.57 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.29 | |||||
| Price-to-Median-PS-Value | 0.03 | |||||
| Earnings Yield (Greenblatt) % | -110.89 | |||||
| FCF Yield % | -366700 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BG Medicine Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.418 | ||
| EPS (TTM) (€) | -0.594 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.29 - 4.36 | ||
| Shares Outstanding (Mil) | 11.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BG Medicine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BG Medicine Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BG Medicine Inc Frequently Asked Questions
What is BG Medicine Inc(FRA:RBM1)'s stock price today?
The current price of FRA:RBM1 is €0.52. The 52 week high of FRA:RBM1 is €4.36 and 52 week low is €0.29.
When is next earnings date of BG Medicine Inc(FRA:RBM1)?
The next earnings date of BG Medicine Inc(FRA:RBM1) is .
Does BG Medicine Inc(FRA:RBM1) pay dividends? If so, how much?
BG Medicine Inc(FRA:RBM1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers